Cercetătorii fac progrese în tratarea uneia dintre cele mai grave complicații ale cancerului

Recent research indicates that cachexia, a severe complication of cancer, may become treatable. Scientists have made significant strides in understanding the mechanisms behind this condition, which affects a large percentage of cancer patients. New medications targeting cachexia are currently in advanced clinical trials, showing promising results. One such treatment involves an antibody that blocks the GDF15 protein, which is linked to appetite suppression. Patients receiving this treatment have reported weight gain and increased appetite. Ongoing studies aim to identify biomarkers for early detection and tailored therapies, raising hopes for effective management of cachexia in the future.